Extracorporeal membrane oxygenation and diurnal analgosedation: a comparative retrospective study in ventilated patients
Extracorporeal membrane oxygenation and diurnal analgosedation: a comparative retrospective study in ventilated patients
Background: diurnal variation of analgosedation may worsen patient outcomes. However, there is no data reporting diurnal variation in patients receiving extracorporeal membrane oxygenation (ECMO).
Objectives: to compare diurnal variation of analgosedation doses in mechanically ventilated adult patients and those receiving ECMO.
Setting: five ICUs (65 beds) including an ECMO unit, with patient recruitment from July 2021 to July 2023.
Methods: retrospective single-centre cohort study including patients aged ≥ 16 years receiving continuous intravenous (IV) opioid (fentanyl) and/or sedative (midazolam and/or propofol), receiving mechanical ventilation with or without ECMO. We collected data on all intravenous analgosedation doses (excluding boluses) from 07:00 to 18:59 (day) or from 19:00 to 06:59 (nighttime) for 48 h.
Results: we identified 1277 patients; of whom 166 (13.0 %) received ECMO and 1111 (87.0 %) received no ECMO. Most were male 815 (63.8 %), median (interquartile range (IQR)) age 58 (42–70) years. We found no diurnal variation of analgosedation doses in ECMO patients. However, we found higher doses of fentanyl (mean difference 1.7 µg/kg, 95 % Confidence Interval (CI): 1.0, 2.4 μg/kg, p < 0.001) and propofol (mean difference 2.3 mg/kg, 95 % CI: 1.7, 2.9 mg/kg, p < 0.001) at nighttime compared to daytime in non-ECMO patients. A higher proportion of ECMO patients received neuromuscular blocking drugs compared to non-ECMO group 120 (72.3 %) vs 138 (12.4 %); p < 0.001.
Conclusions: we found higher doses of fentanyl and propofol IV infusion doses at nighttime in non-ECMO patients. However, we found no diurnal variation of analgosedation doses in ECMO patients, most likely due to deep sedation and use of neuromuscular blocking medicines.
Implications for clinical practice: patient factors, critical illness factors and type of ICU admission are likely contributory factors to differences in diurnal variation of analgosedation doses in ECMO and non-ECMO populations.
Remmington, Christopher
73e46f54-40a5-48f2-8890-b8f68c4a8bac
Camporota, Luigi
bdfceef3-a124-4c7a-bb57-d760b64ab170
McKenzie, Cathrine A.
ec344dee-5777-49c5-970e-6326e82c9f8c
Hanks, Fraser
c63dbeda-7643-40dc-8396-85f28778fcfa
Sanderson, Barnaby
01f78fcb-a6f1-4d35-846e-d65f4c151a2a
Rose, Louise
877b0eea-9303-4b80-aa30-a5ddc7e38636
30 April 2024
Remmington, Christopher
73e46f54-40a5-48f2-8890-b8f68c4a8bac
Camporota, Luigi
bdfceef3-a124-4c7a-bb57-d760b64ab170
McKenzie, Cathrine A.
ec344dee-5777-49c5-970e-6326e82c9f8c
Hanks, Fraser
c63dbeda-7643-40dc-8396-85f28778fcfa
Sanderson, Barnaby
01f78fcb-a6f1-4d35-846e-d65f4c151a2a
Rose, Louise
877b0eea-9303-4b80-aa30-a5ddc7e38636
Remmington, Christopher, Camporota, Luigi, McKenzie, Cathrine A., Hanks, Fraser, Sanderson, Barnaby and Rose, Louise
(2024)
Extracorporeal membrane oxygenation and diurnal analgosedation: a comparative retrospective study in ventilated patients.
Intensive and Critical Care Nursing, 89, [104056].
(doi:10.1016/j.iccn.2025.104056).
Abstract
Background: diurnal variation of analgosedation may worsen patient outcomes. However, there is no data reporting diurnal variation in patients receiving extracorporeal membrane oxygenation (ECMO).
Objectives: to compare diurnal variation of analgosedation doses in mechanically ventilated adult patients and those receiving ECMO.
Setting: five ICUs (65 beds) including an ECMO unit, with patient recruitment from July 2021 to July 2023.
Methods: retrospective single-centre cohort study including patients aged ≥ 16 years receiving continuous intravenous (IV) opioid (fentanyl) and/or sedative (midazolam and/or propofol), receiving mechanical ventilation with or without ECMO. We collected data on all intravenous analgosedation doses (excluding boluses) from 07:00 to 18:59 (day) or from 19:00 to 06:59 (nighttime) for 48 h.
Results: we identified 1277 patients; of whom 166 (13.0 %) received ECMO and 1111 (87.0 %) received no ECMO. Most were male 815 (63.8 %), median (interquartile range (IQR)) age 58 (42–70) years. We found no diurnal variation of analgosedation doses in ECMO patients. However, we found higher doses of fentanyl (mean difference 1.7 µg/kg, 95 % Confidence Interval (CI): 1.0, 2.4 μg/kg, p < 0.001) and propofol (mean difference 2.3 mg/kg, 95 % CI: 1.7, 2.9 mg/kg, p < 0.001) at nighttime compared to daytime in non-ECMO patients. A higher proportion of ECMO patients received neuromuscular blocking drugs compared to non-ECMO group 120 (72.3 %) vs 138 (12.4 %); p < 0.001.
Conclusions: we found higher doses of fentanyl and propofol IV infusion doses at nighttime in non-ECMO patients. However, we found no diurnal variation of analgosedation doses in ECMO patients, most likely due to deep sedation and use of neuromuscular blocking medicines.
Implications for clinical practice: patient factors, critical illness factors and type of ICU admission are likely contributory factors to differences in diurnal variation of analgosedation doses in ECMO and non-ECMO populations.
Text
Diurnal_sedation_paper_cleaned_version_R2_ICCN
- Accepted Manuscript
Restricted to Repository staff only until 30 April 2026.
Request a copy
More information
Accepted/In Press date: 15 April 2024
e-pub ahead of print date: 30 April 2024
Published date: 30 April 2024
Identifiers
Local EPrints ID: 501825
URI: http://eprints.soton.ac.uk/id/eprint/501825
ISSN: 0964-3397
PURE UUID: 8ed66c5b-742a-4168-a521-0734dfc79b5c
Catalogue record
Date deposited: 10 Jun 2025 17:01
Last modified: 22 Aug 2025 02:41
Export record
Altmetrics
Contributors
Author:
Christopher Remmington
Author:
Luigi Camporota
Author:
Cathrine A. McKenzie
Author:
Fraser Hanks
Author:
Barnaby Sanderson
Author:
Louise Rose
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics